The Viborg Vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocol.

ABSTRACT:

Background

Screening for abdominal aortic aneurysm (AAA) of men aged 65-74 years reduces the AAA-related mortality and is generally considered cost effective. Despite of this only a few national health care services have implemented permanent programs. Around 10% of men in this group have peripheral arterial disease (PAD) defined by an ankle brachial systolic blood pressure index (ABI) below 0.9 resulting in an increased mortality-rate of 25-30%. In addition well-documented health benefits may be achieved through primary prophylaxis by initiating systematic cholesterol-lowering, smoking cessation, low-dose acetylsalicylic acid (aspirins), exercise, a healthy diet and blood-pressure control altogether reducing the increased risks for cardiovascular disease by at least 20-25%. The be

SUBMITTER: Grondal N 

PROVIDER: S-EPMC2891736 | biostudies-literature | 2010 May

REPOSITORIES: biostudies-literature